| Â | AUC | 95%CI | p value | NRI | 95%CI | p value | IDI | 95%CI | p value |
|---|
Baseline risk model | 0.618 | 0.582 ~ 0.655 | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
+TG | 0.619 | 0.583 ~ 0.656 | 0.773 | 0.026 | -0.102 ~ 0.154 | 0.690 | 0.001 | -0.001 ~ 0.003 | 0.293 |
+FBG | 0.631 | 0.595 ~ 0.668 | 0.069 | 0.191 | 0.064 ~ 0.317 | 0.003 | 0.007 | 0.002 ~ 0.012 | 0.009 |
+TyG index groups | 0.636 | 0.600 ~ 0.672 | 0.042 | 0.257 | 0.129 ~ 0.386 | < 0.001 | 0.008 | 0.003 ~ 0.014 | 0.003 |
- Baseline risk model includes age, male, BMI, SBP, current smoking, family history of CAD, hypertension, dyslipidemia, T2DM, prior MI, prior PCI, prior stroke, PAD, clinical diagnosis, eGFR, LVEF, DAPT, ACEI/ARB, antidiabetic agents, statins at discharge, LM disease, multivessel disease, CTO, in-stent restenosis, target vessel selection, number of LIMA, number of SVG, number of treated lesions, number of stents
- AUC, area under the curve; CI, confidence interval; NRI, net reclassification improvement; IDI, integrated discrimination improvement; TG, triglyceride; FBG, fasting blood glucose; TyG, triglyceride-glucose; Ref, reference; other abbreviations as in Table 1
